Sales of Casgevy, a gene-edited treatment developed with CRISPR Therapeutics, more than tripled compared to the third quarter, a performance analysts saw as a bright spot in Vertex's report.
Q4 2025 Earnings Call February 12, 2026 8:00 AM ESTCompany ParticipantsGiuseppe Di Salvo - VP of Investor Relations ...
Radware Ltd. (NASDAQ:RDWR) Q4 2025 Earnings Call Transcript February 11, 2026 Radware Ltd. beats earnings expectations.
Jobs report today: Unemployment rate climbs to 4-year high of 4.6%, November report shows Follow MarketWatch's live coverage of the last big jobs reports of the year, as investors home in on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results